Why a CR now if its not a great deal? For a company which already holds circa 3mil cash position and very decent assays which have already been proven to be very good (good visuals in cores) then it'd be very disappointing if they raise at discount to current ⁸SP. This imo will be disappointing for current shareholders especially considering the fact that more assays are due with pictures showing visible gold in those cores before even assayed. I think FG1 are onto something very significant here... My speculation is that someone else does too and wants a bigger slice of the pie. All imo dyor
Add to My Watchlist
What is My Watchlist?
